Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders
The American Journal of Geriatric Pharmacotherapy, 10/07/2010
Guay DRP – Tetrabenazine is a complicated drug in terms of its mechanism of action and its activities against the 3 major monoamines in the CNS, making it difficult to predict its efficacy and tolerability in patients with hyperkinetic movement disorders. It is associated with numerous adverse effects and several important drug–drug interactions. Much work remains to be done to determine the therapeutic potential of Tetrabenazine in the treatment of hyperkinetic movement disorders.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.